Novel naphthalimide-benzoic acid conjugates as potential apoptosis-inducing agents: Design, synthesis, and biological activity

Chemical Biology and Drug Design

Volumn 78, Issue 6, 2011, Pages 941-947

  Wu, Aibin ^a,b   Mei, Ping ^a   Xu, Yufang ^b   Qian, Xuhong ^b  

^a YANGTZE UNIVERSITY   (China)

^b EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; Benzoic acid; Cell cycle arrest; Conjugate; Cytotoxicity; Naphthalimide

Indexed keywords

AMONAFIDE; BENZOIC ACID; NAPHTHALIMIDE DERIVATIVE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; CYTOTOXICITY; DRUG CONJUGATION; DRUG DESIGN; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZOIC ACID; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; HL-60 CELLS; HUMANS; NAPHTHALIMIDES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 81355133815     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2011.01232.x     Document Type: Article

References (39)

1. Tao Z., Lin N. (2006) Chk1 inhibitors for novel cancer treatment. Anticancer Agents Med Chem;6:377-388.
2. Braña M.F., Cacho M., Gradillas A., de Pascual-Teresa B., Ramos A. (2001) Intercalators as anticancer drugs. Curr Pharm Des;7:1745-1780.
3. 3-4-nitro- and -4-amino-1, 8-naphthalimide conjugates. Inorg Chem;47:401-403.
4. Ghosh U., Bhattacharyya N.P. (2005) Benzamide and 4-amino-1, 8-naphthalimide treatment inhibit telomerase activity by down-regulating the expression of telomerase associated protein and inhibiting the poly(ADP-ribosyl)ation of telomerase reverse transcriptase in cultured cells. FEBS J;272:4237-4248.
5. Liu Y., Xu Y., Qian X., Liu J., Shen L., Li J., Zhang Y. (2006) Novel fluorescent markers for hypoxic cells of naphthalimides with two heterocyclic side chains for bioreductive binding. Bioorg Med Chem;14:2935-2941.
6. Braña M.F., Cacho M., García M.A., de Pascual-Teresa B., Ramos A., Domínguez M.T., Pozuelo J.M., Abradelo C., Rey-Stolle M.F., Yuste M., Báñez-Coronel M., Lacal J.C. (2004) New analogues of amonafide and elinafide, containing aromatic heterocycles: synthesis, antitumor activity, molecular modeling, and DNA binding properties. J Med Chem;47:1391-1399.
7. Quaquebeke E.V., Mahieu T., Dumont P., Dewelle J., Ribaucour F., Simon G., Sauvage S., Gaussin J.F., Tuti J., Yazidi M.E., Vynckt F.V., Mijatovic T., Lefranc F., Darro F., Kiss R. (2007) 2, 2, 2-Trichloro-N-({2-[2-(dimethylamino)ethyl]-1, 3- dioxo-2, 3-dihydro-1H-benzo[de]isoquinolin-5-yl}carbamoyl)acetamide (UNBS3157), a novel nonhematoto- xic naphthalimide derivative with potent antitumor activity. J Med Chem;50:4122-4134.
8. Hariprakasha H.K., Kosakowska-Cholody T., Meyer C., Cholody W.M., Stinson S.F., Tarasova N.I., Michejda C.J. (2007) Optimization of naphthalimide-imidazo- acridone with potent antitumor activity leading to clinical candidate (HKH40A, RTA 502). J Med Chem;50:5557-5560.
9. Qian X., Li Y., Xu Y., Ding J., Lin L., Miao Z., Zhu H., Qu B. (2004) Sulfur-containing naphthoylimide derivatives. WO 2004101570.
10. Malviya V.K., Liu P.Y., Alberts D.S. (1992) Evaluation of amonafide in cervical cancer: phase II. Am J Clin Oncol;15:41-44.
11. Sami S.M., Dorr R.T., Alberts D.S., Remers W.A. (1993) 2-Substituted 1, 2-dihydro-3H-dibenz[de, h]isoquinoline- 1, 3-diones. A new class of antitumor agent. J Med Chem;36:765-770.
12. Thompson J., Pratt C.B., Stewart C.F., Avery L., Bowman L., Zamboni W.C., Pappo A. (1998) Phase I study of DMP840 in pediatric patients with refractory solid tumors. Invest New Drugs;16:45-49.
13. Scozzafava A., Owa T., Mastrolorenzo A., Supuran C.T. (2003) Anticancer and antiviral sulfonamides. Curr Med Chem;10:925-953.
14. Krtolica A. (2005) Stem cell: balancing aging and cancer. Int J Biochem Cell Biol;37:935-941.
15. Zhang Z., Jin L., Qian X., Wei M., Wang Y., Wang J., Yang Y., Xu Q., Xu Y., Liu F. (2007) Novel Bcl-2 inhibitors: discovery and mechanism study of small organic apoptosis-inducing agents. Chembiochem;8:113-121.
16. Lehnert M. (1996) Clinical multidrug resistance in cancer: a multifactorial problem. Eur J Cancer;32:912-920.
17. Loo T.W., Clarke D.M. (2000) Blockage of drug resistance in vitro by disulfiram, a drug used to treat alcoholism. J Natl Cancer Inst;92:898-902.
18. Tang G., Nikolovska-Coleska Z., Qiu S., Yang C., Guo J., Wang S. (2008) Acylpyrogallols as inhibitors of antiapoptotic Bcl-2 proteins. J Med Chem;51:717-720.
19. Thompson C.B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science;267:1456-1462.
20. Lessene G., Czabotar P.E., Colman P.M. (2008) Bcl-2 family antagonists for cancer therapy. Nat Rev Drug Discov;7:989-1000.
21. Danial N.N., Korsmeyer S.J. (2004) Cell death: critical control points. Cell;116:205-219.
22. Oltersdorf T., Elmore S.W., Shoemaker A.R., Armstrong R.C., Augeri D.J., Belli B.A., Bruncko M. et al. (2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature;435:677-681.
23. L. J Am Chem Soc;128:16206-16212.
24. L from NMR and parallel synthesis. J Med Chem;49:656-663.
25. L. J Med Chem;50:641-662.
26. Tang G., Ding K., Nikolovska-Coleska Z., Yang C., Qiu S., Shangary S., Wang R., Guo J., Gao W., Meagher J., Stuckey J., Krajewski K., Jiang S., Roller P.P., Wang S. (2007) Structure-based design of flavonoid compounds as a new class of small-molecule inhibitors of the anti-apoptotic Bcl-2 proteins. J Med Chem;50:3163-3166.
27. Baraldi P.G., Balboni G., Pavani M.G., Spalluto G., Tabrizi M.A., Clercq E.D., Balzarini J., Bando T., Sugiyama H., Romagnoli R. (2001) Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cycloprop- ylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders. J Med Chem;44:2536-2543.
28. Tietze L.F., Bell H.P., Chandrasekhar S. (2003) Natural product hybrids as new leads for drug discovery. Angew Chem Int Ed;42:3996-4028.
29. Corson T.W., Aberle N., Crews C.M. (2008) Design and applications of bifunctional small molecules: why two heads are better than one. ACS Chem Biol;3:677-692.
30. Norton J.T., Witschi M.A., Luong L., Kawamura A., Ghosh S., Stack M.S., Sim E., Avram M.J., Appella D.H., Huang S. (2008) Synthesis and anticancer activities of 6-amino amonafide derivative. Anticancer Drug;19:23-36.
31. Noël G., Godon C., Fernet M., Giocanti N., Mégnin-Chanet F., Favaudon V. (2006) Radiosensitization by the poly(ADP-ribose) polymerase inhibitor 4-amino-1, 8-naphthalimide is specific of the S phase of the cell cycle and involves arrest of DNA synthesis. Mol Cancer Ther;5:564-574.
32. Zuse A., Schmidt P., Baasner S., Böhm K.J., Müller K., Gerlach M., Günther E.G., Unger E., Prinz H. (2007) Sulfonate derivatives of naphtho[2, 3-b]thiophen-4(9H)-one and 9(10H)-anthracenone as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization. J Med Chem;50:6059-6066.
33. L-templated assembly of its own protein-protein interaction modulator from fragments decorated with thio acids and sulfonyl azides. J Am Chem Soc;130:13820-13821.
34. Kuroda M., Mimaki Y., Sashida Y., Hirano T., Oka K., Dobashi A. (1997) Novel cholestance glycosides from the bulbs of ornithogalum saundersiae and their cytostatic activity on leukemia HL-60 and MOLT-4 cells. Tetrahedron;53:11549-11562.
35. Khosravi A., Moradian S., Gharanjig K., Taromi F.A. (2006) Synthesis and spectroscopic studies of some naphthalimide based disperse azo dyestuffs for the dyeing of polyester fibres. Dyes Pigm;69:79-92.
36. Li F., Cui J., Guo L., Qian X., Ren W., Wang K., Liu F. (2007) Molecular design, chemical synthesis, and biological evaluation of '4-1' pentacyclic aryl/heteroaryl-imidazonaphthalimides. Bioorg Med Chem;15:5114-5121.
37. Wu A., Xu Y., Qian X., Wang J., Liu J. (2009) Novel naphthalimide derivatives as potential apoptosis-inducing agents: design, synthesis and biological evaluation. Eur J Med Chem;44:4674-4680.
38. Wu A., Xu Y., Qian X. (2009) Novel naphthalimide-amino acid conjugates with flexible leucine moiety as side chain: design, synthesis and potential antitumor activity. Bioorg Med Chem;17:592-599.
39. Lee S., Kim H., Kang Y., Lee C.W., Kim H.M., Han D.C., Shin J., Bae K., Kwon B.M. (2008) Obovatol inhibits colorectal cancer growth by inhibiting tumor cell proliferation and inducing apoptosis. Bioorg Med Chem;16:8397-8402.